Diff for "Funding" - Bader Lab @ The University of Toronto

Differences between revisions 30 and 42 (spanning 12 versions)

Funding Agency		Title	Grant Period
	Ontario Institute for Cancer Research	Acute Leukemia Translational Initiative (Operating Grant) Pl: John Dick	2017-2021
	Natural Sciences and Engineering Research Council of Canada	Cell and tissue communication networks Pl: Gary Bader	2016-2021
	Canada First Research Excellence Fund	Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant). PI: Molly Shoichet. Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”	2016-2019
	Canada First Research Excellence Fund	Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). PIs: Gary Bader, Freda Miller, David Kaplan, Derek van der Kooy, Michael Moran, Aaron Wheeler, Cindi Morshead, Quaid Morris, Michael Hoffman, Lincoln Stein, Sidhartha Goyal, Trevor Pugh, Michael Wilson. Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”	2016-2019
	Canada First Research Excellence Fund	Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). PIs: John Dick, Norman Iscove, Mathieu Lupien, Gary Bader, Quaid Morris, Igor Jurisica, Shana Kelley. Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”	2016-2019
	Canadian Institutes of Health Research	From correlation to causation in genomics: identifying mechanisms underlying disease (Foundation Grant) Pl: Gary Bader	2015-2022
	The Terry Fox Research Institute	Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047) Pl: John Dick	2015-2020
	U.S. NIH	A human binary interactome reference map by 2020 (Operational sub-grant:U41-HG001715-18). PIs: Marc Vidal, Michael Calderwood, David Hill, Frederick Roth.	2015-2018
	Stand Up To Cancer	Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15) Pls: Peter Dirks, Samuel Weiss, Michael Taylor, Nada Jabado, Cheryl Arrowsmith, Michael Salter, Marco Marra, Mathieu Lupien, Amy Caudy, Trevor Pugh, Gary Bader, Michael Tyers, Wendy Durigon, Warren Mason, Eric Bouffet.	2015-2019
	Natural Sciences and Engineering Research Council of Canada	The Cancer Genome Collaboratory (Operating Grant: Discovery Frontiers) Pls: Lincoln Stein, Gary Bader, Alexandre Bouchard- Cote, Gillaume Bourque, Paul Boutros, Khaled El Emam, Vincent Ferretti, Bartha Knoppers, Francis Ouellette, Cenk Sahinalp, Sohrab Shah, Brian Shoichet.	2014-2018
	Ontario Institute for Cancer Research	Cancer stem cell program (Operating Grant) Pl: John Dick	2013-2017
	Genome Canada	Personalised Risk Stratification for Prevention and Early Detection of Breast Cancer (Operating Sub-Grant) Pls: Bartha Maria Knoppers, and Jacques Simard.	2013-2017
	U.S. NIH via National Center for Research Resources (NCRR)	National Resource for Network Biology (NRNB), PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader. This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)	2012-2017
	U.S. NIH via National Institute of General Medical Sciences (NIGMS)	Cytoscape: A Modeling Platform for Biomolecular Networks Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Human Genome Research Institute (NHGRI) under award number HG009979. Cytoscape user support, education and new initiatives are supported by the National Resource for Network Biology (NRNB) under award numbers P41 RR031228 and GM103504. PIs: Trey Ideker, Gary Bader.	2009-2017
	U.S. NIH via National Human Genome Research Institute (NHGRI)	Pathway Commons Research resource for biological pathways. Pathway Commons is a collaboration between the Bader Lab at the University of Toronto, the Sander Lab at the cBio Center for Information Biology, Dana-Farber Cancer Institute and the Computational biology collaboratory at Harvard Medical School, and the Demir Lab, Oregon Health & Science University (Grant: U41 HG006623).	2008-2018
	Canadian Institutes of Health Research	A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324) Pl: Gary Bader	2007-2017
	U.S. NIH	Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research (Operating Sub-Grant: 69119295) PIs: Jill Mesirov and Gary Bader.	2006-2017

-  ⇤ ← Revision 30 as of 2017-01-13 18:42:14 → 
  Size: 6263
  Editor: ShanGao
  Comment:
+   ← Revision 42 as of 2020-09-29 18:42:09 → ⇥
  Size: 7421
  Editor: AnnaCorpuz
  Comment:
-Deletions are marked like this.
+Additions are marked like this.
 Line 3:
-||||<style="background-color: #E0E0FF; font-weight: bold; text-align: center;">Funding Agency||<style="background-color: #E0E0FF; font-weight: bold; text-align: center;">Title||<style="background-color: #E0E0FF; font-weight: bold; text-align: center;">Period||
||<style="text-align:center;">{{attachment:CIHR.jpg}}||[[ http://www.cihr-irsc.gc.ca/|Canadian Institutes of Health Research]] || A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324)||2007-2017||
+||||<style="background-color: #E0E0FF; font-weight: bold; text-align: center;">Funding Agency||<style="background-color: #E0E0FF; font-weight: bold; text-align: center;">Title||<style="background-color: #E0E0FF; font-weight: bold; text-align: center;">Grant Period||
||<style="text-align:center;">{{attachment:OICR.jpeg||width=150}}||[[ https://oicr.on.ca/oicr-programs-and-platforms/innovation-programs/cancer-stem-cell |Ontario Institute for Cancer Research]]||Acute Leukemia Translational Initiative (Operating Grant) <<BR>><<BR>>Pl: John Dick||2017-2021||
||<style="text-align: center;">{{attachment:NSERC.png||width=200}}||[[http://www.nserc-crsng.gc.ca/|Natural Sciences and Engineering Research Council of Canada]]|| Cell and tissue communication networks<<BR>><<BR>>Pl: Gary Bader||2016-2021||
||<style="text-align: center;">{{attachment:CFREF.jpg}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant). <<BR>><<BR>> PI: Molly Shoichet.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”||2016-2019||
||<style="text-align: center;">{{attachment:CFREF.jpg}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). <<BR>><<BR>> PIs: Gary Bader, Freda Miller, David Kaplan, Derek van der Kooy, Michael Moran, Aaron Wheeler, Cindi Morshead, Quaid Morris, Michael Hoffman, Lincoln Stein, Sidhartha Goyal, Trevor Pugh, Michael Wilson.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”||2016-2019||
||<style="text-align: center;">{{attachment:CFREF.jpg}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). <<BR>><<BR>> PIs: John Dick, Norman Iscove, Mathieu Lupien, Gary Bader, Quaid Morris, Igor Jurisica, Shana Kelley.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”|| 2016-2019||
-Line 6:
+Line 10:
+||<style="text-align:center;">{{attachment:NewTerryFox.jpg||width=250}}||[[http://www.tfri.ca/|The Terry Fox Research Institute]]|| Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047) <<BR>><<BR>>Pl: John Dick||2015-2020||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]]|| [[http://interactome.baderlab.org/|A human binary interactome reference map by 2020]] (Operational sub-grant:U41-HG001715-18). <<BR>><<BR>> PIs: Marc Vidal, Michael Calderwood, David Hill, Frederick Roth. ||2015-2018||
||<style="text-align: center;">{{attachment:SU2C.jpg||width=200}}||[[http://www.cancerstemcellteam.com/|Stand Up To Cancer]]||Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15) <<BR>><<BR>>Pls: Peter Dirks, Samuel Weiss, Michael Taylor, Nada Jabado, Cheryl Arrowsmith, Michael Salter, Marco Marra, Mathieu Lupien, Amy Caudy, Trevor Pugh, Gary Bader, Michael Tyers, Wendy Durigon, Warren Mason, Eric Bouffet.||2015-2019||
-Line 7:
+Line 14:
-||<style="text-align: center;">{{attachment:NSERC.png||width=200}}||[[http://www.nserc-crsng.gc.ca/|Natural Sciences and Engineering Research Council of Canada]]|| Cell and tissue communication networks||2016-2021||
-Line 9:
+Line 15:
-||<style="text-align: center;">{{attachment:SU2C.jpg||width=200}}||[[http://http://www.cancerstemcellteam.com/|Stand Up To Cancer]]||Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15) <<BR>><<BR>>Pls: Peter Dirks, Samuel Weiss, Michael Taylor, Nada Jabado, Cheryl Arrowsmith, Michael Salter, Marco Marra, Mathieu Lupien, Amy Caudy, Trevor Pugh, Gary Bader, Michael Tyers, Wendy Durigon, Warren Mason, Eric Bouffet.||2015-2017||
||<style="text-align:center;">{{attachment:Gen.jpg||width=220}}||[[https://www.genomecanada.ca/|Genome Canada]]|| Activity 1: Identification and validation of the effect of common and low frequency genetic variants on breast cancer (Operating Sub-Grant) <<BR>><<BR>>Pls: Jacques Simard and Gary Bader.||2013-2017||
||<style="text-align:center;">{{attachment:Gen.jpg||width=220}}||[[https://www.genomecanada.ca/|Genome Canada]]|| Activity 2: Identification and validation of the rare variants /mutations in novel breast cancer susceptibility (Operating Sub-Grant) <<BR>><<BR>>Pls: Jacques Simard and Gary Bader.||2013-2017||
||<style="text-align:center;">{{attachment:TerryFox.jpg||width=250}}||[[http://www.tfri.ca/|The Terry Fox Research Institute]]|| Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047) <<BR>><<BR>>Pl: John Dick||2015-2020||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://genome.gov/|National Human Genome Research Institute (NHGRI)]]||Pathway Commons Research resource for biological pathways <<BR>><<BR>>[[http://www.pathwaycommons.org/|Pathway Commons]] is a collaboration between the Bader Lab at the University of Toronto, the Sander Lab at the cBio Center for Information Biology, Dana-Farber Cancer Institute and the Computational biology collaboratory at Harvard Medical School, and the Demir Lab, Oregon Health & Science University.||2008-2018||
+||<style="text-align:center;">{{attachment:Gen.jpg||width=220}}||[[https://www.genomecanada.ca/|Genome Canada]]|| Personalised Risk Stratification for Prevention and Early Detection of Breast Cancer (Operating Sub-Grant) <<BR>><<BR>>Pls: Bartha Maria Knoppers, and Jacques Simard.||2013-2017||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.ncrr.nih.gov/|National Center for Research Resources (NCRR)]]||[[http://nrnb.org/|National Resource for Network Biology (NRNB)]], PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader.<<BR>><<BR>>This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)||2012-2017||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.nigms.nih.gov/|National Institute of General Medical Sciences (NIGMS)]]||[[http://www.cytoscape.org/|Cytoscape: A Modeling Platform for Biomolecular Networks]]<<BR>><<BR>>Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Human Genome Research Institute (NHGRI) under award number HG009979.<<BR>><<BR>>Cytoscape user support, education and new initiatives are supported by the National Resource for Network Biology (NRNB) under award numbers P41 RR031228 and GM103504.<<BR>><<BR>>PIs: Trey Ideker, Gary Bader.||2009-2017||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://genome.gov/|National Human Genome Research Institute (NHGRI)]]||Pathway Commons Research resource for biological pathways. <<BR>><<BR>>[[http://www.pathwaycommons.org/|Pathway Commons]] is a collaboration between the Bader Lab at the University of Toronto, the Sander Lab at the cBio Center for Information Biology, Dana-Farber Cancer Institute and the Computational biology collaboratory at Harvard Medical School, and the Demir Lab, Oregon Health & Science University (Grant: U41 HG006623).||2008-2018||
||<style="text-align:center;">{{attachment:CIHR.jpg}}||[[ http://www.cihr-irsc.gc.ca/|Canadian Institutes of Health Research]] || A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324)<<BR>><<BR>>Pl: Gary Bader||2007-2017||
-Line 15:
+Line 21:
-||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.ncrr.nih.gov/|National Center for Research Resources (NCRR)]]||Resource for Analysis, Vizualization, and Integration of Networks (RAVIN), PIs: Trey Ideker, Chris Sander, James Fowler, Bruce Conklin, Gary Bader.<<BR>><<BR>>This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)||2010-2017||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]]|| [[http://interactome.baderlab.org/|A human binary interactome reference map by 2020]] (Operational sub-grant:U41-HG001715-18). <<BR>><<BR>> PIs: Marc Vidal, Michael Calderwood, David Hill, Frederick Roth. ||2015-2018||
||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.nigms.nih.gov/|National Institute of General Medical Sciences (NIGMS)]]||[[http://www.cytoscape.org/|Cytoscape: A Modeling Platform for Biomolecular Networks]]<<BR>><<BR>>Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Institute of General Medical Sciences (NIGMS) under award number GM070743. <<BR>><<BR>>PIs: Trey Ideker, Gary Bader.||2009-2016||
||<style="text-align: center;">{{attachment:CFREF.jpg}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). <<BR>><<BR>> PIs: Gary Bader, Freda Miller, David Kaplan, Derek van der Kooy, Michael Moran, Aaron Wheeler, Cindi Morshead, Quaid Morris, Michael Hoffman, Lincoln Stein, Sidhartha Goyal, Trevor Pugh, Michael Wilson.||2016-2019||
||<style="text-align: center;">{{attachment:CFREF.jpg}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). <<BR>><<BR>> PIs: John Dick, Norman Iscove, Mathieu Lupien, Gary Bader, Quaid Morris, Igor Jurisica, Shana Kelley.|| 2016-2019||